Safety and immunogenicity of Omicron protein vaccines in mRNA-vaccinated adolescents: A phase 3, randomised trial.
Bennett C, Chau G, Clayton E, Chu L, Alvarez J, Hidalgo AB, Palanpurwala K, Plested JS, Zhu M, Cloney-Clark S, Cai Z, Kalkeri R, Hegazy K, Smith K, Neal S, Noriega F, Mallory RM, Adelglass JM; 2019nCoV-314 Study Investigators.
Bennett C, et al. Among authors: clayton e.
J Infect. 2025 Jan 26;90(2):106428. doi: 10.1016/j.jinf.2025.106428. Online ahead of print.
J Infect. 2025.
PMID: 39874991